Latest News about LLY
Recent news which mentions LLY
Medicare’s exclusion of weight-loss drug coverage under fire
November 20, 2023
From MarketWatch
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
From Benzinga
The Relative Strength Index (RSI) Indicator: Does It Work?
November 17, 2023
From InvestorPlace
Eli Lilly Options Trading: A Deep Dive into Market Sentiment
November 17, 2023
Tickers
LLY
From Benzinga
Goldman Sachs' 2024 Equity Outlook: Winning Stocks And Sectors To Watch
November 16, 2023
From Benzinga
Pharmaceutical Giant Eli Lilly Plans Expansion In Germany, Eyes Diabetes Drug Production: Report
November 16, 2023
From Benzinga
10 ‘better values’ in the stock market, selected for the next two years
November 16, 2023
From MarketWatch
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
From Benzinga
Better Growth Stock: Novo Nordisk vs. Eli Lilly
November 16, 2023
From Motley Fool
If You Invested $10,000 in Eli Lilly in 2013, This Is How Much You Would Have Today
November 16, 2023
Tickers
LLY
From Motley Fool
Why Eli Lilly Stock Flopped While the Market Popped Today
November 15, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
From Benzinga
Ozempic Shortage Crisis - Germany Weighs Export Restrictions on Novo Nordisk's Drug
November 15, 2023
From Benzinga
Why It’s Time to Sell These 3 Hot Stocks
November 14, 2023
From InvestorPlace
Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds
November 14, 2023
From MarketWatch
Eli Lilly Is Planning to Dominate the Weight Loss Market and Make Billions. Here's Why It'll Keep Winning
November 14, 2023
From Motley Fool
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
November 13, 2023
From InvestorPlace
What Are Pfizer's Prospects In Obesity Pill Market? Analysts Say Optimism, Cautiousness Surround With Data Awaited Next Year
November 13, 2023
From Benzinga
Is There Room for Improvement In Weight Loss Arena? Analysts Evaluate Novo Nordisk Data, Emphasize Opportunities for Eli Lilly
November 13, 2023
From Benzinga
Verve Therapeutics’ stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
November 13, 2023
From MarketWatch
The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’
November 13, 2023
From InvestorPlace
Better Buy Now: Novo Nordisk vs. Eli Lilly
November 13, 2023
From Motley Fool
Wegovy Weight Loss Drug Cuts Heart Complication Risk, Says Trial
November 11, 2023
From Benzinga
'Market's Had A Very Solid Winning Streak Of Late': Jim Cramer Eyes Key Retailers And CPI Data In Critical Earnings Week Ahead
November 11, 2023
From Benzinga
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
November 11, 2023
From MarketWatch
Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth
November 11, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.